# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3802824 | Binding | Binding affinity to HIV1 protease L10I mutant | Human immunodeficiency virus 1 | 1 | ALA3797033 | assay format | Scientific Literature | |
2. | ALA3802826 | Binding | Binding affinity to HIV1 protease L63P mutant | Human immunodeficiency virus 1 | 1 | ALA3797033 | assay format | Scientific Literature | |
3. | ALA615673 | Binding | Compound is evaluated in vitro for the inhibition single mutant of HIV-1 RT (Y181C) | 1 | ALA1126659 | single protein format | Scientific Literature | ||
4. | ALA650169 | Binding | Inhibitory activity of compound against HIV-1 aspartyl protease. | Human immunodeficiency virus 1 | 51 | ALA1134992 | single protein format | Scientific Literature | |
5. | ALA656164 | Functional | The compound is evaluated for the fold resistance. | 1 | ALA1131244 | assay format | Scientific Literature | ||
6. | ALA659197 | Functional | Antiviral activity against HIV-1 in CEM cells. | 12 | ALA1127713 | cell-based format | Scientific Literature | ||
7. | ALA656267 | Functional | Antiviral activity against HIV-1 in CEM cells | 15 | ALA1127713 | cell-based format | Scientific Literature | ||
8. | ALA654767 | Functional | The compound is evaluated for the fold resistance. | 1 | ALA1131244 | assay format | Scientific Literature | ||
9. | ALA659465 | Functional | Antiviral activity against the HTLV-III strain of HIV-1 in CEM cell lines | 12 | ALA1130791 | cell-based format | Scientific Literature | ||
10. | ALA684606 | Functional | Antiviral activity against HIV-I infected H9 cells | 16 | ALA1128181 | cell-based format | Scientific Literature | ||
11. | ALA684614 | Functional | Inhibition of HIV-1 protease in a cell culture assay using HIV-1 IIIB infected H9 cells. | Human immunodeficiency virus 1 | 32 | ALA1131083 | cell-based format | Scientific Literature | |
12. | ALA685390 | Functional | Inhibition of HIV-1 protease in a cell culture assay using HIV-1 IIIB infected H9 cells. | Human immunodeficiency virus 1 | 32 | ALA1131083 | cell-based format | Scientific Literature | |
13. | ALA683625 | Binding | Antiviral activity against 460.2 clone of HXB2 mutant virus in their protease sequence | 1 | ALA1129048 | single protein format | Scientific Literature | ||
14. | ALA683626 | Binding | Antiviral activity against 460.6 clone of HXB2 mutant virus in their protease sequence | 1 | ALA1129048 | single protein format | Scientific Literature | ||
15. | ALA683628 | Binding | Activity to inhibit mutant HIV-1 rRT activity in Y181C | 3 | ALA1145983 | single protein format | Scientific Literature | ||
16. | ALA683629 | Binding | Tested for inhibitory activity against HIV-1 protease | 1 | ALA1126785 | single protein format | Scientific Literature | ||
17. | ALA874081 | Binding | Compound was tested for its antiviral potency against human immunodeficiency virus type 1 | Human immunodeficiency virus 1 | 1 | ALA1135191 | single protein format | Scientific Literature | |
18. | ALA694655 | Binding | Inhibitory activity against HIV-1 IIIB in CEM-SS infected cells (Experiment 1) | 1 | ALA1132068 | cell-based format | Scientific Literature | ||
19. | ALA694661 | Binding | Inhibitory activity against HIV protease | 7 | ALA1128784 | single protein format | Scientific Literature | ||
20. | ALA694662 | Binding | In vitro inhibitory activity of compound against HIV protease from BRU (IIIB) strain of HIV- 1 virus was determined | Human immunodeficiency virus 1 | 1 | ALA1127974 | single protein format | Scientific Literature |